載入...
Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet
Vildagliptin is a potent and selective inhibitor of dipeptidyl peptidase-IV (DPP-4), orally active, that improves glycemic control in patients with type 2 diabetes (T2DM) primarily by enhancing pancreatic (α and β) islet function. Thus vildagliptin has been shown both to improve insulin secretion an...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2008
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2515409/ https://ncbi.nlm.nih.gov/pubmed/18827867 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|